Log in
Enquire now
‌

US Patent 7473694 Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof

Patent 7473694 was granted and assigned to Teijin Pharma on January, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
‌
Teijin Pharma
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7473694
Patent Inventor Names
Yuko Yamakoshi0
Kenichiro Kataoka0
Mika Takakuwa0
Tomomi Kosugi0
Gen Unoki0
Hiroaki Makino0
Date of Patent
January 6, 2009
Patent Application Number
11377363
Date Filed
March 17, 2006
Patent Primary Examiner
‌
Mark Berch
Patent abstract

A pyrazolopyrimidine derivative represented by formula (1) and pharmaceutically acceptable salt thereof exhibit excellent inhibitory activity against MAPKAP-K2. Accordingly, medicines containing this compound as an active ingredient are expected to be effective for treating diseases mediated by MAPKAP-K2 such as, for example, inflammatory disorder, autoimmune diseases, destructive osteopathy, cancer and/or tumor growth.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7473694 Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.